APA (7th ed.) Citation

Aletaha D, Snedecor SJ, Ektare V, Xue M, Bao Y, & Garg V. (2017). Clinical and economic analysis of outcomes of dose tapering or withdrawal of tumor necrosis factor-α inhibitors upon achieving stable disease activity in rheumatoid arthritis patients. Dove Medical Press.

Chicago Style (17th ed.) Citation

Aletaha D, Snedecor SJ, Ektare V, Xue M, Bao Y, and Garg V. Clinical and Economic Analysis of Outcomes of Dose Tapering or Withdrawal of Tumor Necrosis Factor-α Inhibitors upon Achieving Stable Disease Activity in Rheumatoid Arthritis Patients. Dove Medical Press, 2017.

MLA (9th ed.) Citation

Aletaha D, et al. Clinical and Economic Analysis of Outcomes of Dose Tapering or Withdrawal of Tumor Necrosis Factor-α Inhibitors upon Achieving Stable Disease Activity in Rheumatoid Arthritis Patients. Dove Medical Press, 2017.